Johnson & Johnson Gains FDA Approval for Ottava Robotic Surgery System, Challenging Market Leader Intuitive Surgical
Johnson & Johnson has secured US FDA approval for its Ottava robotic surgery system, marking the company's entry into the soft-tissue surgical robotics market. The device is authorized for multiple upper abdominal procedures and features a compact design requiring 30-50% less space than competing systems.